Results 101 to 110 of about 182,045 (267)

Novel Quinoline- and Naphthalene-Incorporated Hydrazineylidene–Propenamide Analogues as Antidiabetic Agents: Design, Synthesis, and Computational Studies

open access: yesPharmaceuticals
Background: Type 2 diabetes has become a significant global health challenge. Numerous drugs have been developed to treat the condition, either as standalone therapies or in combination when glycemic control cannot be achieved with a single medication ...
Osama Alharbi   +7 more
doaj   +1 more source

Unraveling the Antihyperglycemic Effects of Dipeptyl Peptidase-4 Inhibitors in Rodents: A Multi-Faceted Approach Combining Effects on Glucose Homeostasis, Molecular Docking, and ADMET Profiling

open access: yesPharmaceuticals
Background/Objectives: Dipeptidyl peptidase-4 (DPP-4) inhibitors are antidiabetic agents that regulate blood glucose by preventing the degradation of active incretin hormones.
Raquel N. S. Roriz   +25 more
doaj   +1 more source

Astaxanthin inhibits aldose reductase activity in Psammomys obesus, a model of type 2 diabetes and diabetic retinopathy [PDF]

open access: hybrid, 2019
Maha Benlarbi‐Ben Khedher   +7 more
openalex   +1 more source

Selectivity of N(2)-substituted oxotriazinoindole aldose reductase inhibitors is determined by the interaction pattern with Pro301-Arg312 loop of aldehyde reductase [PDF]

open access: hybrid
Lucia Kováčiková   +9 more
openalex   +1 more source

Molecular cloning of cDNA coding for kidney aldose reductase

open access: hybrid, 1989
A. García-Pérez   +7 more
openalex   +1 more source

1-Hydroxypyrazole as a bioisostere of the acetic acid moiety in a series of aldose reductase inhibitors

open access: green, 2013
Nikolaos Papastavrou   +3 more
openalex   +1 more source

Synthesis and aldose reductase inhibitory activity of thiazolidinecarboxylic acids containing a disulfide bond.

open access: bronze, 1985
Eishin Kato   +9 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy